BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage develop…
Biotechnology
US, Palo Alto [HQ]
BBIO/Leadership and Strategy
Risk Factors
Annual
Not Available
No Risk Factor available yet. You can request "Risk Factors" through an email.
Quarter
Not Available